ID

20225

Beschreibung

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

Stichworte

Versionen (1)
  1. 15.02.17 15.02.17 -
Hochgeladen am

15. Februar 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Treatment Visit 2 Month 1 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Englisch

Treatment Visit 2 Month 1 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulare  
Concomitant Medication
Beschreibung

Concomitant Medication

Alias
UMLS CUI-1
C2347852
1. Since the last visit, were any of the non-study medications listed below taken?
Beschreibung

Concomitant medication

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
If yes, please indicate which of the following were taken:
Beschreibung

If yes, please indicate which

Datentyp

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1524063
ACE Inhibitors
Beschreibung

ACE Inhibitors

Alias
UMLS CUI-1
C0003015
2. Since the last visit, were any ACE inhibitors taken?
Beschreibung

ACE Inhibitors currently taken

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
If yes, please indicate which, and total daily dose:
Beschreibung

If yes

Datentyp

text

Alias
UMLS CUI [1,1]
C0003015
UMLS CUI [1,2]
C1524063
UMLS CUI [2]
C2348070
Restricted Concomitant Medication
Beschreibung

Restricted Concomitant Medication

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0443288
3. Have any restricted medications in the categories defined on the opposite page been taken?
Beschreibung

Restricted medication taken

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1518384
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C2347852
UMLS CUI [1,4]
C0443288
If yes, please indicate which category
Beschreibung

if yes

Datentyp

integer

Alias
UMLS CUI [1,1]
C0683312
UMLS CUI [1,2]
C2347852
UMLS CUI [1,3]
C0443288
Tobacco Use Status
Beschreibung

Tobacco Use Status

Alias
UMLS CUI-1
C0543414
UMLS CUI-2
C0449438
4. Has the patient smoked in the last week?
Beschreibung

Smoked last week

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0543414
UMLS CUI [1,2]
C2987125
If the patient smoked cigarettes number of cigarettes per day
Beschreibung

Number of cigarettes per day

Datentyp

float

Alias
UMLS CUI [1,1]
C0543414
UMLS CUI [1,2]
C3694146
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Treatment Visit 2 Month 1 PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Concomitant Medication
C2347852 (UMLS CUI-1)
Concomitant medication
Item
1. Since the last visit, were any of the non-study medications listed below taken?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
Item
If yes, please indicate which of the following were taken:
integer
C2347852 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes, please indicate which
Code List
If yes, please indicate which of the following were taken:
CL Item
Parental anticoagulants (Short term use)  (1)
CL Item
Oral anticoagulants (Short term use) (2)
CL Item
Nitrates (oral or topical) (3)
CL Item
Estrogen replacement without progesterone (4)
CL Item
Estrogen replacement with progesterone (5)
CL Item
Digitalis (6)
CL Item
Statins (7)
CL Item
Fibrates (8)
CL Item
Dilitazem/Verapamil (9)
CL Item
Other calcium channel blockers (10)
CL Item
Alpha-blocker (11)
CL Item
Direct vasodilators (12)
CL Item
Peripheral sympatholytic (13)
CL Item
Central sympatholytic (14)
CL Item
Alpha-beta blocker (15)
CL Item
Beta-blocker (16)
CL Item
Loop-active diuretics (17)
CL Item
Diuretics of thiazide type (18)
CL Item
Potassium-sparing diuretics (19)
CL Item
Insulin (20)
CL Item
Oral hypoglycemic agents (21)
CL Item
Specific Cox II inhibitors (22)
Item Group
ACE Inhibitors
C0003015 (UMLS CUI-1)
ACE Inhibitors currently taken
Item
2. Since the last visit, were any ACE inhibitors taken?
boolean
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
If yes
Item
If yes, please indicate which, and total daily dose:
text
C0003015 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C2348070 (UMLS CUI [2])
Item Group
Restricted Concomitant Medication
C2347852 (UMLS CUI-1)
C0443288 (UMLS CUI-2)
Restricted medication taken
Item
3. Have any restricted medications in the categories defined on the opposite page been taken?
boolean
C1518384 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
C0443288 (UMLS CUI [1,4])
Item
If yes, please indicate which category
integer
C0683312 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0443288 (UMLS CUI [1,3])
if yes
Code List
If yes, please indicate which category
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
CL Item
6 (6)
CL Item
7 (7)
Item Group
Tobacco Use Status
C0543414 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Smoked last week
Item
4. Has the patient smoked in the last week?
boolean
C0543414 (UMLS CUI [1,1])
C2987125 (UMLS CUI [1,2])
Number of cigarettes per day
Item
If the patient smoked cigarettes number of cigarettes per day
float
C0543414 (UMLS CUI [1,1])
C3694146 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video